Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

ProEducar 2019 | We celebrate 10 Years of continuous interventional education!

Ya salipo el Programa Científico Preliminar del 10° Curso de Fellows de ProEducar

The ProEducar Fellow Course is a special event designed for fellows or interventional trainees seeking to update their knowledge and perfect their skills on interventional cardiology. This intensive and quality event introduces four interventional modules focused on practice rather than theory, with step-by-step demonstrations, tips and secrets of the trade, and educational cases.

The course features latin-american and world renowned interventionists, who will share their knowledge and insights on Complex Coronary Interventions, Structural Heart Disease, Non-Coronary Interventions, Treating Complications and more…

Discover the Scientific Program of the Event HERE

Additionally, we will be presenting the three winners of this year’s ProEducar Clinical Case Contest

    CASE 4453 – Complex Case Valve in Valve Aortic
Dr. Daniel Facundo Ferreyra
Santa Clara Red de Clínicas, Argentina
    CASE 5107 – Left Coronary Trunk Stenosis After Aortic Valve Replacement
Dr. Carlos Giuliani
Sanatorio Finochietto, Argentina
    CASE Nº 5110 – PTCA Bifurcation Guided by Coronary Physiology
Dra. Julia Kurtz Teixeira ODonnell
Instituto de Cardiologia, Brasil
 

Special Award | Grants for SCAI 2019 Fall Fellow Course

At the end of the course, there will be an optional multiple-choice final exam.

The 4 best grades will get an educational grant to participate in the SCAI 2019 Interventional Cardiology Fall Fellow Course, to be held on December 6th-10th, at the Cosmopolitan of Las Vegas Hotel, in Las Vegas, Nevada. SCAI will offer free registration and housing for four nights for the highest grades obtained in the final exam

 

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...